Melinda Magyari, MD, PhD, The Danish Multiple Sclerosis Center, Rigshospitalet, København, Denmark, discusses the range of comorbidities in patients with multiple sclerosis (MS), including the influence of comorbidities on the clinical features and therapeutic challenges in MS. This interview took place during the Virtual World Congress on Controversies in Neurology (CONy) 2020.
Disclosures
Melinda Magyari has served on scientific advisory board for Biogen, Sanofi, Roche, Novartis, Merck, Abbvie, Alexion has received honoraria for lecturing from Biogen, Merck, Novartis, Sanofi, Genzyme, has received research support and support for congress participation from Biogen, Genzyme, Roche, Merck, Novartis.
